purpos
recent
fecal
microbiota
transplant
fmt
test
veterinari
medicin
treatment
option
multipl
gastrointestin
gi
diseas
inflammatori
bowel
diseas
ibd
howev
report
chang
microbi
divers
fecal
microbiom
treatment
fmt
canin
ibd
case
moreov
littl
known
longterm
efficaci
safeti
fmt
treatment
dog
herein
present
case
canin
intract
ibd
treat
repeat
longterm
fmt
patient
method
patient
neuter
male
toy
poodl
prolong
histori
vomit
diarrhea
fecal
examin
pathogen
neg
despit
treatment
multipl
antibacteri
antidiarrh
agent
patient
show
improv
endoscop
mucu
sampl
diagnos
case
lymphocyticplasmacyt
duoden
ie
idiopath
ibd
eventu
perform
period
longterm
fecal
microbiota
transplant
fresh
donor
fece
collect
neuter
male
golden
retriev
rectal
enema
addit
perform
rrna
sequenc
analysi
fmt
evalu
microbiom
divers
result
fecal
microbiom
divers
fmt
resembl
healthi
donor
dog
fecal
microbiom
fmt
led
us
conclud
fecal
microbiom
patient
normal
fmt
moreov
clinic
symptom
improv
remark
regard
chang
fecal
microbiom
addit
note
observ
side
effect
fmt
treatment
conclus
report
indic
efficaci
safeti
longterm
period
fmt
case
canin
ibd
base
attenu
clinic
symptom
chang
fecal
microbiom
divers
therefor
fmt
could
chosen
treatment
option
ibd
canin
futur
inflammatori
bowel
diseas
ibd
common
caus
idiopath
chronic
relaps
gastrointestin
gi
diseas
dog
common
histolog
chang
associ
ibd
lymphoplasmacyt
inflamm
howev
eosinophil
neutrophil
inflamm
also
identifi
caus
ibd
unknown
believ
secondari
complex
interplay
genet
immun
dysregul
environment
factor
includ
gi
microbiom
human
medicin
fecal
microbiota
transplant
fmt
report
effect
treatment
recurr
clostridium
fmt
fecal
matter
collect
test
healthi
donor
mix
salin
solut
strain
administ
patient
colonoscopi
endoscopi
sigmoidoscopi
enema
veterinari
medicin
fmt
recent
test
treatment
option
multipl
gi
diseas
ibd
howev
chang
microbiom
divers
treatment
fmt
report
canin
ibd
moreov
whether
fmt
effect
safe
treatment
canin
ibd
still
remain
unknown
herein
present
case
canin
intract
ibd
treat
repeat
longterm
fmt
addit
perform
rrna
sequenc
analysi
evalu
microbiom
divers
treatment
fmt
neuter
male
toy
poodl
present
prolong
histori
vomit
diarrhea
realtim
pcr
analysi
idexx
laboratori
inc
tokyo
japan
dog
fecal
sampl
neg
cryptosporidium
spp
giardia
spp
clostridium
perfringen
toxin
clostridium
difficil
toxin
b
campylobact
jejuni
campylobact
coli
salmonella
spp
canin
parvoviru
type
canin
distemp
viru
canin
enter
coronaviru
gene
dog
treat
metronidazol
mgkg
po
h
antidiarrh
compound
day
howev
consist
stool
improv
subsequ
antibiot
treatment
regimen
chang
orbifloxacin
mgkg
po
hr
antiflatul
administ
day
howev
diarrhea
persist
condit
improv
eventu
patient
refer
nippon
veterinari
life
scienc
univers
endoscopi
treatment
thu
underw
canin
upper
endoscopi
obtain
gastric
duoden
mucosa
biopsi
tylosin
mgkg
po
hr
administ
day
patholog
examin
howev
stool
consist
improv
endoscop
mucos
sampl
reveal
lymphocyticplasmacyt
duoden
idiopath
ibd
diagnos
treat
patient
prednisolonecyclosporin
mgkg
po
hr
mgkg
po
hr
month
stool
consist
initi
show
improv
howev
patient
clinic
condit
stabil
without
medicin
fmt
prescrib
pharmacotherapeut
treatment
discontinu
week
perform
fmt
kept
discontinu
throughout
trial
collect
fresh
donor
fece
neuter
male
golden
retriev
donor
dog
determin
good
health
undergo
physic
clinic
examin
complet
blood
count
serum
biochem
analysi
radiographi
abdomin
ultrasound
fecal
examin
donor
dog
fece
also
evalu
realtim
pcr
analysi
idexx
laboratori
inc
analysi
reveal
pathogen
microb
collect
donor
fece
within
hr
perform
fmt
immedi
fecal
collect
approxim
g
gkg
fece
dissolv
ml
mlkg
ringer
solut
slurri
pass
steril
gauz
filter
particul
matter
total
administ
ml
mlkg
slurri
patient
fmt
procedur
gener
fmt
perform
either
oral
eg
nasoduoden
intub
enteroscopi
rectal
ie
rectal
enema
colonoscopi
addit
report
colonoscopi
fmt
excel
cure
rate
well
toler
therefor
chose
rectal
enema
rout
administr
case
due
efficaci
safeti
report
optimum
dose
treatment
interv
fmt
procedur
thu
determin
interv
fmt
observ
symptom
improv
stool
consist
case
first
fmt
perform
day
total
treat
dog
fmt
time
within
month
result
trial
stool
consist
shown
improv
stabil
fmt
day
howev
day
fmt
patient
owner
recogn
differ
fecal
smell
frequenc
flatu
observ
decid
perform
fmt
everi
week
evalu
chang
clinic
symptom
use
canin
inflammatori
bowel
diseas
activ
index
cibdai
waltham
tm
fecal
condit
score
day
postfmt
patient
frequenc
vomit
defec
decreas
stool
show
normal
consist
cidbai
score
improv
waltham
tm
score
improv
figur
b
advers
effect
occur
throughout
cours
treatment
fmt
rarefact
analysi
rrna
gene
sequenc
perform
use
miseq
report
softwar
illumina
inc
assess
microbiom
divers
raw
sequenc
data
screen
trim
filter
default
set
use
qiim
view
tool
analysi
perform
randomli
select
subset
sequenc
sampl
rrna
gene
sequenc
analyz
identif
select
bacteri
group
includ
actinobacteria
bacteroidet
firmicut
fusobacteria
proteobacteria
bacteria
analysi
show
differ
proport
bacteri
popul
fece
fmt
compar
fmt
donor
fecal
sampl
figur
fmt
predomin
bacteri
phylum
proteobacteria
firmicut
compris
total
bacteri
popul
actinobacteria
compris
bacteroidet
compris
fusobacteria
detect
day
fmt
proport
proteobacteria
decreas
wherea
fusobacteria
significantli
increas
moreov
proport
domin
bacteri
group
firmicut
bacteroidet
increas
microbiom
fece
patient
complet
fmt
treatment
similar
healthi
donor
dog
addit
chang
microbi
divers
coincid
improv
cibdai
score
patient
dog
describ
case
report
present
long
histori
vomit
diarrhea
upper
endoscop
examin
reveal
lymphocyticplasmacyt
duoden
ie
idiopath
ibd
convent
treatment
consist
antiflatul
agent
antidiarrh
agent
antibiot
antiinflammatori
drug
improv
dog
symptom
diarrhea
vomit
use
fmt
employ
symptom
improv
fmt
treatment
total
treat
dog
fmt
time
within
month
observ
decid
perform
fmt
everi
week
herein
conclud
dog
intract
ibd
achiev
clinic
resolut
repeat
longterm
fmt
perform
rrna
sequenc
analysi
evalu
microbi
divers
fece
dog
ibd
round
treatment
fmt
previou
studi
report
proport
proteobacteria
fusobacteria
fecal
microbiom
healthi
dog
studi
proport
proteobacteria
fusobacteria
fece
healthi
donor
dog
fmt
proport
proteobacteria
high
fece
patient
howev
fusobacteria
undetect
identifi
signific
differ
fecal
microbiom
divers
patient
healthi
dog
dysbiosi
refer
abnorm
constitut
microbiom
commonli
observ
anim
acut
chronic
gastrointestin
diseas
furthermor
gener
assum
gammaproteobacteria
includ
proteobacteria
evok
dysbiosi
caus
imbal
enter
environ
lower
proport
fusobacteria
patient
fece
healthi
dog
howev
sever
studi
report
fusobacterium
implic
proinflammatori
found
higher
abund
ibd
patient
mous
model
human
suggest
fusobacterium
caus
colitisassoci
colorect
cancer
mous
model
human
although
fusobacteria
may
risk
factor
mous
human
low
rate
fusobacteria
may
specif
canin
ibd
therefor
popul
proteobacteria
fusobacteria
may
relat
clinic
gi
symptom
present
case
canin
ibd
propos
high
proport
proteobacteria
low
proport
fusobacteria
may
characterist
featur
canin
ibd
fmt
procedur
signific
decreas
proport
proteobacteria
signific
increas
proport
fusobacteria
domin
bacteri
group
firmicut
bacteroidet
fecal
microbiom
divers
similar
donor
fecal
microbiom
allow
us
conclud
divers
fecal
microbiom
normal
fmt
present
case
canin
ibd
moreov
observ
confirm
chang
fecal
microbiom
divers
inde
affect
clinic
symptom
ibd
henc
contribut
efficaci
fmt
treatment
although
report
indic
fmt
safe
procedur
shortterm
treatment
studi
report
safeti
longterm
fmt
procedur
sinc
complet
round
continu
perform
fmt
regularli
everi
week
till
date
observ
side
effect
includ
diarrhea
vomit
abdomin
pain
associ
fmt
procedur
therefor
report
longterm
fmt
treatment
canin
ibd
safe
studi
use
fece
one
healthi
donor
dog
fmt
futur
studi
examin
efficaci
safeti
fmt
use
fece
multipl
healthi
donor
addit
perform
endoscopi
patient
fmt
due
lack
consent
owner
therefor
unabl
confirm
chang
intestin
mucosa
result
fmt
case
fmt
trial
treatment
case
henc
cost
also
risk
anesthesia
side
effect
observ
point
trial
therefor
continu
perform
fmt
everi
week
far
improv
symptom
keep
conclus
show
efficaci
safeti
fmt
case
report
conclud
fmt
consid
treatment
option
canin
ibd
intract
ibd
case
futur
written
inform
consent
obtain
owner
patient
dog
public
case
report
studi
approv
ethic
committe
nippon
veterinari
life
scienc
univers
permiss
number
confirm
revis
manuscript
treatment
meet
standard
set
primat
guidelin
follow
veterinari
care
best
practic
guidelin
abbrevi
cibdai
canin
inflammatori
bowel
diseas
activ
index
fmt
fecal
microbiota
transplant
ibd
inflammatori
bowel
diseas
gi
gastrointestin
